SRT3025 HCl is primarily used in scientific research focused on aging and metabolic regulation. It acts as a potent activator of SIRT1, a member of the sirtuin family of proteins involved in cellular health, stress response, and longevity pathways. Due to its ability to enhance SIRT1 activity, it is studied for potential applications in age-related diseases, including neurodegenerative disorders, type 2 diabetes, and cardiovascular conditions. In preclinical studies, SRT3025 HCl has shown promise in improving mitochondrial function and insulin sensitivity, making it a candidate for metabolic disease research. It has also demonstrated neuroprotective effects in models of Alzheimer’s and Parkinson’s diseases by reducing inflammation and oxidative stress in neuronal tissues. Additionally, this compound is used to investigate the role of sirtuins in cancer biology, where modulation of SIRT1 can influence tumor growth and cell survival. Its use remains confined to laboratory and experimental settings, mainly in cell cultures and animal models, supporting the development of therapies targeting aging and metabolic dysfunction.